Just ten months after it launched, Cellink went public, being listed on the Nasdaq. Its shares were oversubscribed by 1,070 percent. Trading began on November 2016, a year after the INKREDIBLE 3D

CELLINK AB (SE:CLNKB) has 13 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).

A huge thank you to all of CELLINK’s customers, shareholders, and investors for your trust and partnership. CELLINK är ett nischat life-science bolag som utvecklar och levererar life-science lösningar för cellkultivering. Vi fokuserar på tre applikationsområden som inkluderar bioprinting, analysis och liquid handling & bioprocessing för att möjliggöra ett komplett erbjudande inom vår … CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications.

Cellink ipo

Högkullen - Tecknar. Se CELLINK har skapat ett av världens första universella biobläck som idag används av många av världens mest välrenommerade forskningsinstitutioner. Ett biobläck kan blandas med levande celler för att skriva ut funktionella mänskliga vävnader och om framtida forskning är framgångsrik, på sikt, kompletta mänskliga organ i så kallade 3D-Bioskrivare. The input range of great ideas are endless at CELLINK, all from our creative customers, hard working team and extensive internal testing. Our tech team of mechanical, electronics, robotics and software engineers as well as our UX/UI designers, biomaterial scientist and tissue engineers make it possible for us to fully develop our bioprinters, bioinks and softwares in-house.

Ett biobläck kan blandas med levande celler för att skriva ut funktionella mänskliga vävnader och om framtida forskning är framgångsrik, på sikt, kompletta mänskliga organ i så kallade 3D-Bioskrivare. Køb CELLINK AB ser.

Cellink has raised a total of $4.3M in funding over 2 rounds. Their latest funding was raised on Mar 4, 2020 from a Grant round. Cellink is registered under the ticker OTCPINK:CLKKF . Cellink is funded by 2 investors. Vinnova and EASME - EU Executive Agency for SMEs are the most recent investors. Cellink has acquired 5 organizations.

Portfolio Companies. Number of Portfolio Companies 5,605.

Se hela listan på en.wikipedia.org

Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues Co-founders Erik Gatenholm and Héctor Martínez at Cellink’s first IPO in October 2016. Image courtesy of Cellink. On April 20, 2020, Cellink AB is a bioconvergence company, which provides technologies, products and services to create, understand and master biology. It focuses on the application areas of bioprinting, multiomics Investors may trade in the Pre-Market (4:00-9:30 a.m.

The AGM has decided to carry out the stock 15 Jan 2018 Erik Gatenholm, co-founder of award-winning bioprinting firm Cellink, But even after the IPO, we went back to our hotel room, took care of 28 mar 2018 Känns som att det kan bli "nästa Cellink-case". Saxar ett inlägg från BS hit: " Fluicell - Årets första riktigt bra IPO? Angående Fluicell - Jag tycker 26 Jan 2017 2 IPOs are from Swedish companies. Sweden also saw the youngest company going public, Cellink founded in 2016. Mainstay Medical, a 21. März 2021 In unserem Aktien-Check sprechen wir über die Crowdstrike Aktie, die Rio Tinto Aktie, die Cellink Aktie, die Tencent Aktie und die Xinyi Solar Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry.
Schenker viared

In 2016, when the company was officially founded, Cellink’s IPO was already more than 1070% over-subscribed. As a result, the founder Erik Gatenholm was placed on the Forbes’ “30 under 30” list in 2018, becoming Entrepreneur of the Year.

Das Unternehmen wurde 2016 gegründet und die IPO fand im selben Jahr statt. CELLINK had only been in existence for ten months before they decided to pursue their IPO in November of 2016, listing on Nasdaq First North after a 1070% oversubscribed IPO, which means that Senaste nytt om ZignSec aktie. ZignSec komplett bolagsfakta från DI.se Video-filmer om investeringar och aktier.
Maskinoperatör utbildning göteborg

August 19, 2020 Regulatory CELLINK has completed directed share issues of SEK 946 million to finance the acquisition of SCIENION AG and create further room for a continued M&A agenda August 19, 2020 Regulatory CELLINK announces intention to carry out directed share issues of approximately 13.5% of the outstanding shares to finance the acquisition of SCIENION AG

CELLINK har skapat ett av världens första universella biobläck som idag används av många av världens mest välrenommerade forskningsinstitutioner. Ett biobläck kan blandas med levande celler för att skriva ut funktionella mänskliga vävnader och om framtida forskning är framgångsrik, på sikt, kompletta mänskliga organ i så kallade 3D-Bioskrivare. 2019-08-05 Apple iPod Classic 4G Accessories Product List See Below for Cellink's range of Accessories to suit the Apple iPod Classic 4G Filter Products By Category: Select Category Accessories & Data AV & MP3 Accessories Batteries & Power Banks Bluetooth Solutions Carrying & Styling Chargers Spare Parts Apple iPod mini Accessories Product List See Below for Cellink's range of Accessories to suit the Apple iPod mini Filter Products By Category: Select Category Accessories & Data AV & MP3 Accessories Batteries & Power Banks Bluetooth Solutions Carrying & Styling Chargers Phone Repair Tools Spare Parts Apple,Cellular Phone Models and Accessories. iPad Air (2019) 3rd Gen iPod batteries are now available for repairing a majority of models.

4 Jun 2019 hours on the market, Cellink listed on the Nasdaq First North stock exchange merely 10 months later after a 1070 percent oversubscribed IPO

REPLACEMENT CELLS Bioprintningsföretaget CELLINK har genomfört en riktad nyemission som tillför bolaget cirka 377 miljoner kronor Further to the press release published on 11 March 2021, CELLINK AB (publ) ("CELLINK" or the "Company") announces the pricing of (i) an issue of Senior Unsecured Convertible Bonds due 2026 (the CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications.

Mainstay Medical, a 21. März 2021 In unserem Aktien-Check sprechen wir über die Crowdstrike Aktie, die Rio Tinto Aktie, die Cellink Aktie, die Tencent Aktie und die Xinyi Solar Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting , Cellink is a bioconvergence startup that designs and supplies technologies and services to enhance At its IPO, shares were oversubscribed by 1070 percent. UPM Biomedicals develops and supplies innovative and sustainable wood- based biomedical products for a variety of uses.